These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 19270655)

  • 1. Geron gets green light for human trial of ES cell-derived product.
    Alper J
    Nat Biotechnol; 2009 Mar; 27(3):213-4. PubMed ID: 19270655
    [No Abstract]   [Full Text] [Related]  

  • 2. Caution urged in trial of stem cells to treat spinal-cord injury.
    Barde Y
    Nature; 2009 Mar; 458(7234):29. PubMed ID: 19262651
    [No Abstract]   [Full Text] [Related]  

  • 3. First patient enters trial to test safety of stem cells in spinal injury.
    Mayor S
    BMJ; 2010 Oct; 341():c5724. PubMed ID: 20940208
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluating the first-in-human clinical trial of a human embryonic stem cell-based therapy.
    Chapman AR; Scala CC
    Kennedy Inst Ethics J; 2012 Sep; 22(3):243-61. PubMed ID: 23285793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. World's first clinical trial of human embryonic stem cell therapy cleared.
    Geron Corporation
    Regen Med; 2009 Mar; 4(2):161. PubMed ID: 19322956
    [No Abstract]   [Full Text] [Related]  

  • 6. Oligodendrocyte progenitor cells: a missed opportunity.
    Watson RA; Tsakok MT; Yeung TM
    J Neurotrauma; 2012 Nov; 29(16):2593-4. PubMed ID: 22845890
    [No Abstract]   [Full Text] [Related]  

  • 7. Biotechnology. Celebration and concern over U.S. trial of embryonic stem cells.
    Couzin J
    Science; 2009 Jan; 323(5914):568. PubMed ID: 19179496
    [No Abstract]   [Full Text] [Related]  

  • 8. Human embryonic stem cell-derived oligodendrocyte progenitors for the treatment of spinal cord injury.
    Faulkner J; Keirstead HS
    Transpl Immunol; 2005 Dec; 15(2):131-42. PubMed ID: 16412957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stem cells ready for prime time.
    Wadman M
    Nature; 2009 Jan; 457(7229):516. PubMed ID: 19177087
    [No Abstract]   [Full Text] [Related]  

  • 10. What is the potential of oligodendrocyte progenitor cells to successfully treat human spinal cord injury?
    Watson RA; Yeung TM
    BMC Neurol; 2011 Sep; 11():113. PubMed ID: 21943254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Target populations for first-in-human embryonic stem cell research in spinal cord injury.
    Bretzner F; Gilbert F; Baylis F; Brownstone RM
    Cell Stem Cell; 2011 May; 8(5):468-75. PubMed ID: 21549321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Consider using diffusion tensor imaging in Geron phase I trial.
    Patel CB
    AJNR Am J Neuroradiol; 2009 Aug; 30(7):E97. PubMed ID: 19386734
    [No Abstract]   [Full Text] [Related]  

  • 13. Transplantation of human embryonic stem cell-derived oligodendrocyte progenitors into rat spinal cord injuries does not cause harm.
    Cloutier F; Siegenthaler MM; Nistor G; Keirstead HS
    Regen Med; 2006 Jul; 1(4):469-79. PubMed ID: 17465839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell biology. Ready or not? Human ES cells head toward the clinic.
    Vogel G
    Science; 2005 Jun; 308(5728):1534-8. PubMed ID: 15947149
    [No Abstract]   [Full Text] [Related]  

  • 15. Perspectives and future directions of human pluripotent stem cell-based therapies: lessons from Geron's clinical trial for spinal cord injury.
    Lukovic D; Stojkovic M; Moreno-Manzano V; Bhattacharya SS; Erceg S
    Stem Cells Dev; 2014 Jan; 23(1):1-4. PubMed ID: 23980630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Embryonic stem cells. Researchers mull impact of Geron's sudden exit from field.
    Kaiser J
    Science; 2011 Nov; 334(6059):1043. PubMed ID: 22116849
    [No Abstract]   [Full Text] [Related]  

  • 17. Preclinical safety of human embryonic stem cell-derived oligodendrocyte progenitors supporting clinical trials in spinal cord injury.
    Priest CA; Manley NC; Denham J; Wirth ED; Lebkowski JS
    Regen Med; 2015 Nov; 10(8):939-58. PubMed ID: 26345388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human Embryonic Stem Cell-Derived Oligodendrocyte Progenitor Cells: Preclinical Efficacy and Safety in Cervical Spinal Cord Injury.
    Manley NC; Priest CA; Denham J; Wirth ED; Lebkowski JS
    Stem Cells Transl Med; 2017 Oct; 6(10):1917-1929. PubMed ID: 28834391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stem-cell treatments for spinal-cord injury may be worth the risk.
    Owens J
    Nature; 2009 Apr; 458(7242):1101. PubMed ID: 19407774
    [No Abstract]   [Full Text] [Related]  

  • 20. [Embryonic stem cells. Future perspectives].
    Groebner M; David R; Franz WM
    Internist (Berl); 2006 May; 47(5):502, 504-8. PubMed ID: 16609891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.